Investment
Features
FeesSafety
Academy
More
Pluang+

Yiren Digital confirms operational independence amid investigation of controlling shareholder affiliates

Market News
14 Oct 2026
PRNewsWire
View Source
Neutral
Yiren Digital confirms operational independence amid investigation of controlling shareholder affiliates

Yiren Digital Ltd., a fintech and AI company listed on NYSE, clarified that it operates independently despite an ongoing investigation involving affiliates of its controlling shareholder. The investigation concerns activities unrelated to Yiren Digital's core business, which focuses on AI-driven financial services and insurance brokerage. The company has acknowledged provisions for credit losses on related-party loans but maintains sufficient cash reserves and plans to continue its $20 million share repurchase program. Yiren Digital emphasizes compliance, transparency, and prudent management while advancing its AI technology platform.

Yiren Digital's operational update is provided with Pluang's Financials-sector market snapshot as of Oct 14, 2026 15:11 WIB: Among 142 priced US Financials stocks tradable on Pluang, 92 rose and 38 fell today. Notable movers include Moody's Corporation (MCO) at USD 475.13 with a 1-day change of +2.37% and a typical hold time of 133 days, Mizuho Financial Group Inc. (MFG) at USD 10.39 down 1.98%, and Mitsubishi UFJ Financial Group Inc. (MUFG) at USD 21.97 down 1.92% with 100% sell order activity. The most notable figure is Moody's Corporation's price at USD 475.13.

More News

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall raises $4M to launch AI-driven autonomous attack agents for continuous enterprise security testing.

CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...

Others
Bullish
1 hour ago
Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics names John O’Malley as Chief Medical Officer to advance autoimmune drug pipeline.

Matchpoint Therapeutics has appointed John O’Malley, M.D., Ph.D., as its Chief Medical Officer. Dr. O’Malley brings extensive experience in immunology and clinical development from his previous roles at CRISPR Therapeutics and Sanofi. His leadership ...

Market News
Bullish
2 hours ago
FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

FDA accepts Orvida Pharma's KM-023 into Rare Disease Evidence Principles process for Olmsted syndrome

Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...

Market News
Bullish
2 hours ago
DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global to release Q3 2026 financial results on October 27 after market close

DMC Global Inc. will announce its financial results for the third quarter ending September 30, 2026, on October 27 after the stock market closes. The company will hold a conference call and webcast to discuss the results, providing investors with ins...

Company Fundamentals
Neutral
2 hours ago
Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware launches MCP Server Protection to secure AI integration layers from attacks and abuse.

Radware introduced its Model Context Protocol (MCP) Server Protection solution to help organizations secure the integration layer where AI agents connect to enterprise applications and workflows. This new security tool provides visibility into MCP in...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App